Hubei Biocause Heilen Pharmaceutical Co Ltd
301211
Company Profile
Business description
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.
Contact
No. 122, Yangwan Road
Dadao District, Jingmen High-tech Zone
Hubei Province
Jingmen448000
CHNT: +86 7242223339
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
987
Stocks News & Analysis
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
stocks
Moated ASX share crashes amid weak trading update
Bapcor signalled lower underlying profits for fiscal 2025, while an audit cast doubt on the firm’s past earnings.
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,015.40 | 48.70 | 0.54% |
| CAC 40 | 7,875.49 | 18.13 | 0.23% |
| DAX 40 | 24,266.63 | 49.26 | 0.20% |
| Dow JONES (US) | 44,558.69 | 74.30 | -0.17% |
| FTSE 100 | 9,129.46 | 6.86 | -0.08% |
| HKSE | 25,176.93 | 347.52 | -1.36% |
| NASDAQ | 21,140.28 | 41.99 | 0.20% |
| Nikkei 225 | 40,654.70 | 19.85 | -0.05% |
| NZX 50 Index | 12,855.97 | 80.44 | -0.62% |
| S&P 500 | 6,371.38 | 0.52 | 0.01% |
| S&P/ASX 200 | 8,756.40 | 51.80 | 0.60% |
| SSE Composite Index | 3,615.72 | 6.01 | 0.17% |